Er-Kang, The Big Winner of Three Major Awards in the Annual Summit of Chemical Pharmaceutical Industry

The conformity with marketing authorization is released to Kang Pharmaceutical starch capsule, which will be launched into market soon.ER-Kang Pharmaceutical Company wins the major awards of " 2013 Top 100 Brands in Comprehensive Strength in China’s Chemical Pharmaceutical Industry”(rank the seventy-eighth ), " 2013 Growth Type Pharmaceutical Adjuvant Enterprise in China’s Chemical Pharmaceutical Industry ” (rank the first), and “ Outstanding Industrial Brand of China’s Chemical Pharmaceutical Industry (rank the first) "  in  the 2013 Annual Summit of China’s Chemical Pharmaceutical Industry held in Jiangsu Suzhou in November 12th -------- an event, in which, about 21 types of awards related to  products, quality, and environmental protection are honored. 

As an event to celebrate the 25th anniversary of Chinese Chemical Pharmaceutical Industry Association and as well a grand annual gathering of pharmaceutical enterprises, this summit, with the theme of “Quality, Trust, and Brand”, aims to push on industrial brand building, to strengthen enterprises’ awareness of product quality and social responsibility, and to promote stable and sustainable development in the market competition. Jointly sponsored by China Chemical Pharmaceutical Industry Association, Chinese Medicine Trade Association, China Non-Prescription Drug Association, Chinese Pharmaceutical Enterprises, and Reed Sinopharm Exhibitions Co. Ltd., this summit is attended by the leaders and experts from the State Food and Drug Administration, the Ministry of Industry and Information Technology, the National Development and Reform Commission, and the representatives of multiple enterprises from the industry. 

Under the leadership of the chairman of the company Mr. Shuai Fanwen and driven by the strategy of “one body with two wings”, namely, research and innovation as the body and resources integration of and capital operation as the two wings, the company had achieved annual sales of 835 million in 2012 from the initial sales of 1 million, demonstrating a tremendous growth of 1000 times within 10 years. . Following 2011, the milestone year of the company successfully going public, ER-Kang has been changing rapidly, with 8 subsidiaries and 1 Grandson Company successively established around the world. Meanwhile, the company’s value orientation of “Everything we do for safety of drug” is becoming widely recognized by the society, and Er-Kang brand continuously wins more praise and good reputation from the whole industry. In this summit, Er-kang is honored as China’s top 100 enterprise in chemical pharmaceutical industry and top 1 pharmaceutical adjuvant enterprise in the industry, which shows that it is highly recognized by the whole chemical pharmaceutical industry for its contribution to promoting the development of the industry, especially to the formation of pharmaceutical adjuvant sector and the establishment of related adjuvant standards. It is the first time in years that a special award is set separately for the pharmaceutical adjuvant in chemical pharmaceutical industry, said the Organizing Committee of the Summit at the awarding ceremony.